These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16731183)

  • 1. Bivalirudin anticoagulation for a patient with hypercoagulable immune syndromes undergoing mitral valve surgery.
    Cain RL; Spiess BD; Nelson M; Deanda A; McCarthy HL; Green JA
    Ann Thorac Surg; 2006 Jun; 81(6):2308-10. PubMed ID: 16731183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
    Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
    Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulant monitoring techniques in a heparin-induced thrombocytopenia patient undergoing cardiopulmonary bypass using bivalirudin anticoagulant.
    Baker T; Chan R; Hill F
    J Extra Corpor Technol; 2004 Dec; 36(4):371-4. PubMed ID: 15679282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
    Ortel TL
    Hematology Am Soc Hematol Educ Program; 2009; ():225-32. PubMed ID: 20008202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopenia: diagnosis and management.
    Warkentin TE
    Circulation; 2004 Nov; 110(18):e454-8. PubMed ID: 15520327
    [No Abstract]   [Full Text] [Related]  

  • 6. Bivalirudin use in carotid endarterectomy in a patient with heparin-induced thrombocytopenia.
    Finks SW
    Ann Pharmacother; 2006 Feb; 40(2):340-3. PubMed ID: 16449539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia.
    Clayton SB; Acsell JR; Crumbley AJ; Uber WE
    Ann Thorac Surg; 2004 Dec; 78(6):2167-9. PubMed ID: 15561064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial.
    Koster A; Dyke CM; Aldea G; Smedira NG; McCarthy HL; Aronson S; Hetzer R; Avery E; Spiess B; Lincoff AM
    Ann Thorac Surg; 2007 Feb; 83(2):572-7. PubMed ID: 17257990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful use of bivalirudin for combined carotid endarterectomy and coronary revascularization with the use of cardiopulmonary bypass in a patient with an elevated heparin-platelet factor 4 antibody titer.
    Avery EG; Hilgenberg AD; Cambria RP; Beckerly R; Donnelly AM; Laposata M
    Anesth Analg; 2009 Apr; 108(4):1113-5. PubMed ID: 19299772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on heparin-induced thrombocytopenia and cardiovascular interventions.
    Spiess BD
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S22-7. PubMed ID: 16105555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fulminant coagulopathy after bivalirudin use in a patient diagnosed with heparin-induced thrombocytopenia and subject to cardiac bypass surgery].
    de Prada Martín B; Gualis Cardona J; Pérez Blanco I; Martínez Comendador JM
    Rev Esp Anestesiol Reanim; 2014 Mar; 61(3):157-61. PubMed ID: 23601838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.
    Faella KH; Whiting D; Fynn-Thompson F; Matte GS
    J Extra Corpor Technol; 2016 Mar; 48(1):39-42. PubMed ID: 27134308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bivalirudin anticoagulation for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia.
    Wasowicz M; Vegas A; Borger MA; Harwood S
    Can J Anaesth; 2005 Dec; 52(10):1093-8. PubMed ID: 16326682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies.
    Dyke CM; Aldea G; Koster A; Smedira N; Avery E; Aronson S; Spiess BD; Lincoff AM
    Ann Thorac Surg; 2007 Sep; 84(3):836-9. PubMed ID: 17720385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia.
    Almond CS; Harrington J; Thiagarajan R; Duncan CN; LaPierre R; Halwick D; Blume ED; Del Nido PJ; Neufeld EJ; McGowan FX
    J Heart Lung Transplant; 2006 Nov; 25(11):1376-9. PubMed ID: 17097505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia.
    Dyke CM; Koster A; Veale JJ; Maier GW; McNiff T; Levy JH
    Ann Thorac Surg; 2005 Jul; 80(1):299-303. PubMed ID: 15975385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.
    Mahaffey KW; Lewis BE; Wildermann NM; Berkowitz SD; Oliverio RM; Turco MA; Shalev Y; Ver Lee P; Traverse JH; Rodriguez AR; Ohman EM; Harrington RA; Califf RM;
    J Invasive Cardiol; 2003 Nov; 15(11):611-6. PubMed ID: 14608128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
    Athar U; Husain J; Hudson J; Lynch J; Gajra A
    Am J Hematol; 2008 Mar; 83(3):245-6. PubMed ID: 17910040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case 1-2006: off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: a patient with heparin-induced thrombocytopenia syndrome type II and renal failure.
    Spiess BD; DeAnda A; McCarthy HL; Yeatman D; Katlaps G; Cooper C; Koster A; Aldea GS; Gravlee GP
    J Cardiothorac Vasc Anesth; 2006 Feb; 20(1):106-11. PubMed ID: 16458228
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel techniques in the use of bivalirudin for cardiopulmonary bypass anticoagulation in a child with heparin-induced thrombocytopenia.
    Dragomer D; Chalfant A; Biniwale R; Reemtsen B; Federman M
    Perfusion; 2011 Nov; 26(6):516-8. PubMed ID: 21828161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.